These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21431899)

  • 1. A novel compound heterozygous ROMK mutation presenting as late onset Bartter syndrome associated with nephrocalcinosis and elevated 1,25(OH)(2) vitamin D levels.
    Sharma A; Linshaw MA
    Clin Exp Nephrol; 2011 Aug; 15(4):572-6. PubMed ID: 21431899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolated nephrocalcinosis due to compound heterozygous mutations in renal outer medullary potassium channel.
    Khandelwal P; Sabanadesan J; Sinha A; Hari P; Bagga A
    CEN Case Rep; 2020 Aug; 9(3):232-236. PubMed ID: 32185747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel mutation in KCNJ1 in a Bartter syndrome case diagnosed as pseudohypoaldosteronism.
    Nozu K; Fu XJ; Kaito H; Kanda K; Yokoyama N; Przybyslaw Krol R; Nakajima T; Kajiyama M; Iijima K; Matsuo M
    Pediatr Nephrol; 2007 Aug; 22(8):1219-23. PubMed ID: 17401586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrocalcinosis as adult presentation of Bartter syndrome type II.
    Huang L; Luiken GP; van Riemsdijk IC; Petrij F; Zandbergen AA; Dees A
    Neth J Med; 2014 Feb; 72(2):91-3. PubMed ID: 24659592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A clinical and hereditary analysis of novel complex heterozygous
    Li XY; Jiang Y; Xu LJ; Duan L; Peng XY; Chen LM; Xia WB; Xing XP
    Zhonghua Nei Ke Za Zhi; 2017 Oct; 56(10):760-762. PubMed ID: 29036958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient hyponatremia of prematurity caused by mild Bartter syndrome type II: a case report.
    Verma S; Chanchlani R; Siu VM; Filler G
    BMC Pediatr; 2020 Jun; 20(1):311. PubMed ID: 32590952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel compound heterozygous KCNJ1 gene mutation presenting as late-onset Bartter syndrome: Case report.
    Li J; Hu S; Nie Y; Wang R; Tan M; Li H; Zhu S
    Medicine (Baltimore); 2019 Aug; 98(34):e16738. PubMed ID: 31441846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient neonatal hyperkalemia in the antenatal (ROMK defective) Bartter syndrome.
    Finer G; Shalev H; Birk OS; Galron D; Jeck N; Sinai-Treiman L; Landau D
    J Pediatr; 2003 Mar; 142(3):318-23. PubMed ID: 12640382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotype-genotype correlation in antenatal and neonatal variants of Bartter syndrome.
    Brochard K; Boyer O; Blanchard A; Loirat C; Niaudet P; Macher MA; Deschenes G; Bensman A; Decramer S; Cochat P; Morin D; Broux F; Caillez M; Guyot C; Novo R; Jeunemaître X; Vargas-Poussou R
    Nephrol Dial Transplant; 2009 May; 24(5):1455-64. PubMed ID: 19096086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late onset Bartter syndrome: Bartter syndrome type 2 presenting with isolated nephrocalcinosis and high parathyroid hormone levels mimicking primary hyperparathyroidism.
    Yıldız G; Torun Bayram M; Çinleti T; Koç A; Soylu A; Kavukçu S
    J Pediatr Endocrinol Metab; 2022 Oct; 35(10):1298-1301. PubMed ID: 35952717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterozygous mutations of the gene for Kir 1.1 (ROMK) in antenatal Bartter syndrome presenting with transient hyperkalemia, evolving to a benign course.
    Cho JT; Guay-Woodford LM
    J Korean Med Sci; 2003 Feb; 18(1):65-8. PubMed ID: 12589089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eight novel KCNJ1 variants and parathyroid hormone overaction or resistance in 5 probands with Bartter syndrome type 2.
    Zuo J; Guo W; Wang S; Lang Y; Wang S; Shi X; Zhang R; Zhao X; Han Y; Shao L
    Clin Chim Acta; 2020 Dec; 511():248-254. PubMed ID: 33058840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late-Onset Bartter Syndrome Type II Due to a Novel Compound Heterozygous Mutation in
    Tian M; Peng H; Bi X; Wang YQ; Zhang YZ; Wu Y; Zhang BR
    Front Med (Lausanne); 2022; 9():862514. PubMed ID: 35463019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypocalcemia as the Initial Presentation of Type 2 Bartter Syndrome: A Family Report.
    London S; Levine MA; Li D; Spiegel R; Lebel A; Halevy R; Tenenbaum-Rakover Y
    J Clin Endocrinol Metab; 2022 Mar; 107(4):e1679-e1688. PubMed ID: 34751387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding the spectrum of genetic mutations in antenatal Bartter syndrome type II.
    Fretzayas A; Gole E; Attilakos A; Daskalaki A; Nicolaidou P; Papadopoulou A
    Pediatr Int; 2013 Jun; 55(3):371-3. PubMed ID: 23782368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inherited primary renal tubular hypokalemic alkalosis: a review of Gitelman and Bartter syndromes.
    Shaer AJ
    Am J Med Sci; 2001 Dec; 322(6):316-32. PubMed ID: 11780689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late-Onset Bartter Syndrome Type II Due to a Homozygous Mutation in KCNJ1 Gene: A Case Report and Literature Review.
    Elfert KA; Geller DS; Nelson-Williams C; Lifton RP; Al-Malki H; Nauman A
    Am J Case Rep; 2020 Sep; 21():e924527. PubMed ID: 32997650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome.
    Konrad M; Vollmer M; Lemmink HH; VAN DEN Heuvel LPWJ; Jeck N; Vargas-Poussou R; Lakings A; Ruf R; Deschênes G; Antignac C; Guay-Woodford L; Knoers NVAM; Seyberth HW; Feldmann D; Hildebrandt F
    J Am Soc Nephrol; 2000 Aug; 11(8):1449-1459. PubMed ID: 10906158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accentuated hyperparathyroidism in type II Bartter syndrome.
    Landau D; Gurevich E; Sinai-Treiman L; Shalev H
    Pediatr Nephrol; 2016 Jul; 31(7):1085-90. PubMed ID: 26857709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoplasmic reticulum-associated degradation of the renal potassium channel, ROMK, leads to type II Bartter syndrome.
    O'Donnell BM; Mackie TD; Subramanya AR; Brodsky JL
    J Biol Chem; 2017 Aug; 292(31):12813-12827. PubMed ID: 28630040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.